Does Epitympanic Obliteration with Bone Pâté in Primary Combined Approach Tympanoplasty Reduce Cholesteatoma Recurrence?
The Journal of International Advanced Otology · 2026
DOI: 10.65717/iao.2026.262199 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of International Advanced Otology, 2026. Verfasst von Junaid Kalliyath und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, William Harvey Hospital East Kent Hospital University Trust, Kent, UK. Hauptthemen laut MEDLINE: Tympanoplasty, Cholesteatoma, Middle Ear.
Abstract (Originalsprache)
BACKGROUND: Cholesteatoma is an invasive temporal bone lesion requiring surgical intervention, but recurrence remains a major challenge. Obliteration of the epitympanum during primary combined approach tympanoplasty (CAT) shows promise in reducing recidivism. METHODS: A retrospective cohort study was conducted on 110 patients who underwent primary CAT for cholesteatoma (September 2014 to January 2023). Patients were divided into a non-obliteration group (n = 56) and an obliteration group (n = 54), based on a change in surgical technique in June 2018. The primary outcome was cholesteatoma recidivism, confirmed by intra-operative findings during revision CAT. Kaplan–Meier survival analysis was used to assess recurrence-free survival. RESULTS: The obliteration group demonstrated a significantly lower rate of recidivism (5.56%) compared to the non-obliteration group (30.36%). This corresponded to an absolute risk reduction of 24.8%, odds ratio of 0.13 (95% CI: 0.04-0.49; P < .005), and an 87% reduction in odds of recurrence. All cases of recidivism in the obliteration group were residual disease, whereas both residual (15%) and recurrent (16%) disease were seen in the non-obliteration group. Kaplan–Meier analysis confirmed superior recurrence-free survival in the obliteration group (P < .001), with sustained benefit over 60 months. STAMCO stage III disease accounted for all recurrences in the obliteration group, highlighting its value in advanced cases. CONCLUSION: Bone p.t. obliteration of the epitympanum during CAT significantly reduces cholesteatoma recurrence, particularly in advanced disease, and should be considered as a routine adjunct to reduce cholesteatoma recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, William Harvey Hospital East Kent Hospital University Trust, Kent, UK.
ORCID-Profile: Junaid Kalliyath, Codruta Neumann
Zitieren
APA
Kalliyath, J., & Neumann, C. (2026). Does Epitympanic Obliteration with Bone Pâté in Primary Combined Approach Tympanoplasty Reduce Cholesteatoma Recurrence?. The Journal of International Advanced Otology. https://doi.org/10.65717/iao.2026.262199
Vancouver
Kalliyath J, Neumann C. Does Epitympanic Obliteration with Bone Pâté in Primary Combined Approach Tympanoplasty Reduce Cholesteatoma Recurrence?. The Journal of International Advanced Otology. 2026. doi:10.65717/iao.2026.262199
BibTeX
@article{Kalliyath2026,
author = {Kalliyath, Junaid and Neumann, Codruta},
title = {Does Epitympanic Obliteration with Bone Pâté in Primary Combined Approach Tympanoplasty Reduce Cholesteatoma Recurrence?},
journal = {The Journal of International Advanced Otology},
year = {2026},
doi = {10.65717/iao.2026.262199}
}
EUVIMED